Evommune Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023
Period EndingDec 2024Dec 2023
Valuation Ratios
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-1.12%
Return on Assets (ROA)-0.55%
Return on Capital Employed (ROCE)-1.46%-0.50%
Leverage & Solvency Ratios
Debt/Equity0.030.02
Liquidity Ratios
Current Ratio2.6411.67
Quick Ratio2.5811.53
Efficiency Ratios
Asset Turnover0.09
Yield & Distribution Ratios
Buyback Yield-0.20%